Risk minimisation materials: Solu-Medrone (methylprednisolone sodium succinate) 40 mg Powder for Injection

This healthcare professional letter advises of a lactose-free formulation change, plans to initiate transition to the lactose-free formulation and risk of serious allergic reactions if formulations are confused.

Source:

electronic Medicines compendium